Literature DB >> 12410942

Advances in the diagnosis of oral premalignant and malignant lesions.

Joel B Epstein1, Lewei Zhang, Miriam Rosin.   

Abstract

The diagnosis and treatment of oral premalignant lesions and squamous cell carcinoma are currently based on histopathologic features, site of involvement and stage of disease. Recent advances in techniques for detecting lesions and predicting their progression or recurrence are reviewed here. Adjuncts for detection of lesions and selection of biopsy sites include vital tissue staining (with toluidine blue) and exfoliative cytology. Advances in diagnosis and staging at the molecular level are expected to affect choice of treatment and patient outcomes. Oral health care providers should be aware of these advances in the evaluation and diagnosis of oral premalignant lesions and squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410942

Source DB:  PubMed          Journal:  J Can Dent Assoc        ISSN: 0709-8936            Impact factor:   1.316


  44 in total

1.  TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells.

Authors:  Sung Hee Lee; Hannah S Hong; Zi Xiao Liu; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Biochem Biophys Res Commun       Date:  2012-06-20       Impact factor: 3.575

2.  Toluidine blue color perception in identification of oral mucosal lesions.

Authors:  Pelin Güneri; Joel B Epstein; Selin Ergün; Hayal Boyacioğlu
Journal:  Clin Oral Investig       Date:  2010-03-25       Impact factor: 3.573

3.  Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.

Authors:  Shigeo Ishikawa; Kenichi Ishizawa; Atsushi Tanaka; Hirohito Kimura; Kenichiro Kitabatake; Ayako Sugano; Kaoru Edamatsu; Shohei Ueda; Mitsuyoshi Iino
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

4.  Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence.

Authors:  Jochen Guck; Stefan Schinkinger; Bryan Lincoln; Falk Wottawah; Susanne Ebert; Maren Romeyke; Dominik Lenz; Harold M Erickson; Revathi Ananthakrishnan; Daniel Mitchell; Josef Käs; Sydney Ulvick; Curt Bilby
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

Review 5.  Detection of surgical margins in oral cavity cancer: the role of dynamic optical contrast imaging.

Authors:  Peter A Pellionisz; Karam W Badran; Warren S Grundfest; Maie A St John
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2018-04       Impact factor: 2.064

6.  [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].

Authors:  Matthias Nitsche; Susanne Koy; Michael Mörz; Rainer Koch; Uwe Eckelt
Journal:  Mund Kiefer Gesichtschir       Date:  2007-11-08

7.  Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.

Authors:  Yui Enomoto; Akira Kimoto; Hiroaki Suzuki; Shin Nishiumi; Masaru Yoshida; Takahide Komori
Journal:  Kobe J Med Sci       Date:  2018-09-11

8.  Actinic lesions in fishermen's lower lip: clinical, cytopathological and histopathologic analysis.

Authors:  Karine Piñera-Marques; Silvia Vanessa Lorenço; Luiz Fernando Ferraz da Silva; Mirian Nacagami Sotto; Paulo Campos Carneiro
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

9.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.

Authors:  Masahiro Sugimoto; David T Wong; Akiyoshi Hirayama; Tomoyoshi Soga; Masaru Tomita
Journal:  Metabolomics       Date:  2009-09-10       Impact factor: 4.290

10.  Urokinase gene 3'-UTR T/C polymorphism is associated with oral cancer.

Authors:  Ming-Hsui Tsai; Wen-Chi Chen; Huey-Yi Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.